tirzepatide the same as semaglutide vs Semaglutide: 2026 Clinical Comparison What Are the Side Effects

Lilly's aggressive clinical strategy positions orforglipron as a potential new standard of care for type 2 diabetes, directly challenging both AstraZeneca's $7.7 billion Farxiga franchise and Novo Nordisk's dominant weight loss portfolio

Telehealth platforms like Doctronic.ai offer convenient access to medical expertise without leaving your home

If your goal is to build lasting habits and maintain results long term, Noom offers a more comprehensive framework that extends beyond the prescriptioncombining GLP-1 treatment with education, coaching, and structured behavioral support

Use whatever youre comfortable with

Starting with a moderate dose helps assess tolerance and effectiveness before moving to a higher strength

Diabetes Care (2019) 42(Suppl 1):S90102